The USPSTF I Statement on Skin Cancer Screening—Not a Disappointment but an Opportunity
Ce dossier présente une mise à jour des recommandations 2016 de l'"US Preventive Services Task Force" concernant le dépistage des cancers de la peau
For the fourth time in the past quarter century, the US Preventive Services Task Force (USPSTF) has concluded that skin cancer screening receives an I statement. This means that once again the USPSTF has decided that “the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.”It is important to acknowledge that these recommendations are for general practitioners (not specialists) and only apply to patients at average risk, which may differ from the typical dermatological practice. Furthermore, these recommendations are focused primarily on melanoma, given that it is responsible for most annual skin cancer–related deaths. In its updated evidence report and systematic review, the USPSTF found no direct evidence about the benefits of screening for keratinocytes (eg, stage at detection and mortality). Nevertheless, as with the USPSTF recommendations from 2001, 2009, and 2016, this latest result may feel disappointing to dermatologists, patients, and organizations that promote skin cancer screening. However, this I statement should be viewed as an opportunity for dermatologists, general practitioners, and patients to address the gaps in research that could inform future USPSTF recommendations.
JAMA Dermatology , éditorial en libre accès, 2022